Inflation Reduction Act and AI set the tone for biotech

Biotechnology is an industry in constant change, and it is currently characterised by regulatory shifts and the embracing of AI. In a newly released report, RBC Capital Markets discusses the factors it believes will shape the biotech landscape going forward. The report focuses on manufacturing challenges, the long-term effects of the Inflation Reduction Act, and the opportunities that the AI implementation brings.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/10/inflation-reduction-act-and-ai-set-the-tone-for-biotech/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se